Atmos Energy Corporation vs Boston Scientific Corporation — how do they compare? Atmos Energy Corporation trades at $168.76 (market cap $28.38B), while Boston Scientific Corporation trades at $51 (market cap $71.46B). The key difference: Boston Scientific Corporation is far larger — about 2.5× Atmos Energy Corporation's market cap, and Atmos Energy Corporation pays a 2.38% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| ATO | BSX | |
|---|---|---|
Market Cap | $28.38B | $71.46B |
Sector | Utilities | Health |
52-Week High | $192.25 | $108.14 |
52-Week Low | $162.44 | $42.63 |
Enterprise Value | $38.18B | $83.55B |
Dividend Yield | 2.38% | — |
Signals from Pluang's Aura AI — not financial advice
Atmos Energy (ATO) trades at $170.19, down 1.04% today, with a bearish technical signal despite recent earnings beats. The company reported Q2 2026 EPS of $1.43, beating expectations by 5.9%, and maintains strong fundamentals with 28.5% net income margin and $4.70B revenue. Recent board appointments and dividend declarations highlight corporate stability, while analyst consensus targets $190.57 with 45% buy ratings.
ATO presents a mixed outlook with solid earnings growth and dividend stability offset by bearish technical indicators and negative cash flow trends. The stock offers value through consistent profitability and infrastructure investments, though investors face risks from high capital expenditures and debt levels that could pressure future returns.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Atmos Energy is the largest publicly traded, fully regulated, pure-play natural gas utility in the United States, serving more than 3 million customers in Texas, Colorado, Kansas, Kentucky, Louisiana, Mississippi, Tennessee, and Virginia. About two thirds of its earnings come from Texas, where it distributes natural gas in northern Texas and owns an intrastate gas pipeline spanning several key shale gas formations and interconnected with five storage facilities.
Read more on ATO →Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →